Apoptotic and autophagic cell death induced by histone deacetylase inhibitors

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2004-12-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.0408345102PMID 15596714PMCID PMC539807
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Histone Deacetylase Inhibitor MS-275 Interacts Synergistically with Fludarabine to Induce Apoptosis in Human Leukemia Cells

  2004cited by this paper
• HDAC inhibitors trigger apoptosis in HPV-positive cells by inducing the E2F–p73 pathway

  2004cited by this paper
• Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells

  2004cited by this paper
• Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is required for induction of autophagy during lumen formation in vitro.

  2004cited by this paper
• Histone deacetylase inhibitors.

  2004cited by this paper
• Autophagy as a cell death and tumor suppressor mechanism

  2004cited by this paper
• A SAGE approach to discovery of genes involved in autophagic cell death.

  2003cited by this paper
• Role of Caspases, Bid, and p53 in the Apoptotic Response Triggered by Histone Deacetylase Inhibitors Trichostatin-A (TSA) and Suberoylanilide Hydroxamic Acid (SAHA)*

  2003cited by this paper
• Cytochrome C-mediated apoptosis.

  2003cited by this paper
• The CD95(APO-1/Fas) DISC and beyond

  2003cited by this paper
• Histone deacetylase in carcinogenesis and its inhibitors as anti-cancer agents.

  2003cited by this paper
• Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor

  2003cited by this paper
• Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene.

  2003cited by this paper
• Genome-wide analyses of steroid- and radiation-triggered programmed cell death in Drosophila.

  2003cited by this paper
• Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously.

  2003cited by this paper
• Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation.

  2003cited by this paper
• Apoptosis A Link between Cancer Genetics and Chemotherapy

  2002cited by this paper
• Autophagy in the Eukaryotic Cell

  2002cited by this paper
• Mechanisms of AIF-Mediated Apoptotic DNA Degradation in Caenorhabditis elegans

  2002cited by this paper
• DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death

  2002cited by this paper
• Cooperation between complexes that regulate chromatin structure and transcription.

  2002cited by this paper
• Inactivation of the apoptosis effector Apaf-1 in malignant melanoma

  2001cited by this paper
• Promoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancer

  2001cited by this paper
• The autophagosomal–lysosomal compartment in programmed cell death

  2001cited by this paper
• DAP kinase-a proapoptotic gene that functions as a tumor suppressor.

  2001cited by this paper
• Endonuclease G is an apoptotic DNase when released from mitochondria

  2001cited by this paper
• Mitochondrial endonuclease G is important for apoptosis in C. elegans

  2001cited by this paper
• The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species

  2001cited by this paper
• Life-or-death decisions by the Bcl-2 protein family.

  2001cited by this paper
• Approaching the Molecular Mechanism of Autophagy

  2001cited by this paper
• Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer.

  2000cited by this paper
• Autophagy as a regulated pathway of cellular degradation.

  2000cited by this paper
• The Hallmarks of Cancer Review

  2000cited by this paper
• The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability

  2000cited by this paper
• Safety and antitumor activity of recombinant soluble Apo2 ligand.

  1999cited by this paper
• Autophagy is activated by apoptotic signalling in sympathetic neurons: an alternative mechanism of death execution.

  1999cited by this paper
• Induction of autophagy and inhibition of tumorigenesis by beclin 1

  1999cited by this paper
• Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21.

  1999cited by this paper
• Biochemical pathways of caspase activation during apoptosis.

  1999cited by this paper
• Molecular characterization of mitochondrial apoptosis-inducing factor

  1999cited by this paper
• Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis.

  1998cited by this paper
• Caspases: enemies within.

  1998cited by this paper
• Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors.

  1998cited by this paper
• Roles of histone acetyltransferases and deacetylases in gene regulation

  1998cited by this paper
• Apaf1 is required for mitochondrial pathways of apoptosis and brain development.

  1998cited by this paper
• BCL-2 family: regulators of cell death.

  1998cited by this paper
• Death receptors: signaling and modulation.

  1998cited by this paper
• Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.

  1996cited by this paper

• Shaping death: how the microbiome regulates tumour cell demise and therapy response

  2026cites this paper
• Linking Short-Chain Fatty Acids to Systemic Homeostasis: Mechanisms, Therapeutic Potential, and Future Directions

  2025cites this paper
• Targeting mTORC1 to promote ferroptosis and apoptosis in endometrial cancer with PI3K-Akt-mTOR pathway mutation

  2025cites this paper
• Climate change-induced stress in the honey bee Apis mellifera L.- a genetic review

  2025cites this paper
• Exploring Autophagy Inducing Molecules: Targeting Diverse Pathways in Alzheimer's Disease Management

  2025cites this paper
• Clinical progress and functional modalities of HDAC inhibitor-based combination therapies in cancer treatment

  2025cites this paper
• Design and synthesis of novel Hydroxamate and non-Hydroxamate HDAC inhibitors based on Chromone and Quinazolone scaffolds.

  2025cites this paper
• Genetic-bioengineering of nanotechnology in cell-specific pharmaceutical targeting: Biological, pharmacological, and biochemical impact of nanomaterials-based breast cancer therapies

  2024cites this paper
• A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective against Hepatocellular Carcinoma and Induces Durable Responses with Immunotherapy

  2024cites this paper
• LP340, a novel histone deacetylase inhibitor, decreases liver injury and fibrosis in mice: role of oxidative stress and microRNA-23a

  2024cites this paper
• Impact of Complex Apoptotic Signaling Pathways on Cancer Cell Sensitivity to Therapy

  2024cites this paper
• Mechanistic Sequence of Histone Deacetylase Inhibitors and Radiation Treatment: An Overview

  2024influential citation
• Endoplasmic reticulum stress-mediated autophagy in cancer and its interaction with apoptosis and ferroptosis.

  2024cites this paper
• Structure-Guided Discovery of Subtype Selective SIRT6 Inhibitors with a β-Carboline Skeleton for the Treatment of Breast Cancer.

  2024cites this paper
• A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective Against Hepatocellular Carcinoma and Induces Durable Responses with Immunotherapy

  2024cites this paper
• Exploration of Hydrazide-Based HDAC8 PROTACs for the Treatment of Hematological Malignancies and Solid Tumors

  2024cites this paper
• Emerging therapeutic strategies in cancer therapy by HDAC inhibition as the chemotherapeutic potent and epigenetic regulator

  2024cites this paper
• From pixels to phenotypes: Integrating image-based profiling with cell health data as BioMorph features improves interpretability

  2024cites this paper
• Unraveling the gut health puzzle: exploring the mechanisms of butyrate and the potential of High-Amylose Maize Starch Butyrate (HAMSB) in alleviating colorectal disturbances

  2024cites this paper
• Ageing, Proteostasis, and the Gut: Insights into Neurological Health and Disease.

  2024cites this paper
• Gut microbiota and oleoylethanolamide in the regulation of intestinal homeostasis

  2023cites this paper
• Dynamic Effects of Ketogenic Diet on Autophagy and Cell Cycle in a Mouse Model of CT26+ Colon Cancer

  2023cites this paper
• Tubacin Histone Deacetylase 6 Inhibitor Produced α-Tubulin Acetylation, Cell Cycle Arrest, Aging, and Suppression of Migration of Mouse Fibroblasts Transformed by E1A and cHa-ras Oncogenes

  2023cites this paper
• Regulatory miRNAs in cancer cell recovery from therapy exposure and its implications as a novel therapeutic strategy for preventing disease recurrence.

  2023cites this paper
• The epigenetic regulation of cancer cell recovery from therapy exposure and its implications as a novel therapeutic strategy for preventing disease recurrence.

  2023cites this paper
• Histone Deacetylase 4 Inhibition Reduces Rotenone-Induced Alpha-Synuclein Accumulation via Autophagy in SH-SY5Y Cells

  2023cites this paper
• A Comprehensive Review on Targeted Cancer Therapy: New Face of Treatment Approach.

  2023cites this paper
• Molecular milieu of autophagy in cervical cancer and its therapeutic implications.

  2023cites this paper
• YF343, a Novel Histone Deacetylase Inhibitor, Combined with CQ to Inhibit- Autophagy, Contributes to Increased Apoptosis in Triple-Negative Breast Cancer.

  2023cites this paper
• Free Fatty Acids from Cow Urine DMSO Fraction Induce Cell Death in Breast Cancer Cells without Affecting Normal GMSCs

  2023cites this paper
• From Pixels to Phenotypes: Integrating Image-Based Profiling with Cell Health Data Improves Interpretability

  2023cites this paper
• Inositol hexaphosphate enhances chemotherapy by reversing senescence induced by persistently activated PERK and diphthamide modification of eEF2.

  2023cites this paper
• What we have learnt from Drosophila model organism: the coordination between insulin signaling pathway and tumor cells

  2022influential citation
• Therapeutic Aspects and Molecular Targets of Autophagy to Control Pancreatic Cancer Management

  2022cites this paper
• CDK4/6 Inhibition Enhances the Efficacy of Standard Chemotherapy Treatment in Malignant Pleural Mesothelioma Cells

  2022cites this paper
• Epigenetic dysregulation in autophagy signaling as a driver of viral manifested oral carcinogenesis.

  2022cites this paper
• Selective inhibition of histone deacetylase 3 by novel hydrazide based small molecules as therapeutic intervention for the treatment of cancer.

  2022cites this paper
• Molecular insights on selective and specific inhibitors of Cyclin Dependent Kinase 9 enzyme (CDK9) for the purpose of cancer therapy.

  2022cites this paper
• The gut microbiome as a modulator of healthy ageing

  2022cites this paper
• Grandiflorenic acid from Wedelia trilobata plant induces apoptosis and autophagy cell death in breast adenocarcinoma (MCF7), lung carcinoma (A549), and hepatocellular carcinoma (HuH7.5) cells lines.

  2022cites this paper
• Temporal perturbation of histone deacetylase activity reveals a requirement for HDAC1-3 in mesendoderm cell differentiation.

  2022cites this paper
• The Emerging Role of Janus Kinase Inhibitors in the Treatment of Cancer.

  2022cites this paper
• Histone Acetylation Defects in Brain Precursor Cells: A Potential Pathogenic Mechanism Causing Proliferation and Differentiation Dysfunctions in Mitochondrial Aspartate-Glutamate Carrier Isoform 1 Deficiency

  2022cites this paper
• Brain modulation by the gut microbiota: From disease to therapy

  2022cites this paper
• BMX, a specific HDAC8 inhibitor, with TMZ for advanced CRC therapy: a novel synergic effect to elicit p53-, β-catenin- and MGMT-dependent apoptotic cell death

  2022cites this paper
• The cross-talk of autophagy and apoptosis in breast carcinoma: implications for novel therapies?

  2022cites this paper
• Switching the Mode of Cell Death between Apoptosis and Autophagy by Histone Deacetylase 6 Inhibition Levels

  2022cites this paper
• JNK initiates Beclin-1 dependent autophagic cell death against Akt activation.

  2022cites this paper
• HDAC Inhibitory and Anti-Cancer Activities of Curcumin and Curcumin Derivative CU17 against Human Lung Cancer A549 Cells

  2022cites this paper
• Recent advances in glioblastoma multiforme therapy: A focus on autophagy regulation.

  2022cites this paper
• Epigenetic regulation of autophagy in coronavirus disease 2019 (COVID-19)

  2022cites this paper
• Modified Suberoylanilide Hydroxamic Acid Reduced Drug-Associated Immune Cell Death and Organ Damage under Lipopolysaccharide Inflammatory Challenge.

  2022cites this paper
• First-in-Class Dual Mechanism Ferroptosis-HDAC Inhibitor Hybrids.

  2022cites this paper
• The role of protein acetylation in carcinogenesis and targeted drug discovery

  2022cites this paper
• The gut microbiome and mental health: advances in research and emerging priorities

  2022cites this paper
• Gut Microbiome Regulation of Autophagic Flux and Neurodegenerative Disease Risks

  2021cites this paper
• Inhibition of histone deacetylation with vorinostat does not prevent tunicamycin-mediated acute kidney injury

  2021cites this paper
• Design, synthesis and binding mode of interaction of novel small molecule o-hydroxy benzamides as HDAC3-selective inhibitors with promising antitumor effects in 4T1-Luc breast cancer xenograft model.

  2021cites this paper
• HDAC6 Inhibition Extinguishes Autophagy in Cancer: Recent Insights

  2021cites this paper
• Targeting Autophagy-Related Epigenetic Regulators for Cancer Drug Discovery.

  2021cites this paper
• Vorinostat in autophagic cell death: a critical insight into autophagy-mediated, -associated and -dependent cell death for cancer prevention.

  2021cites this paper
• Dissecting Histone Deacetylase 3 in Multiple Disease Conditions: Selective Inhibition as a Promising Therapeutic Strategy.

  2021cites this paper
• HDAC Inhibitors: Dissecting Mechanisms of Action to Counter Tumor Heterogeneity

  2021cites this paper
• Nanocarrier mediated autophagy: An emerging trend for cancer therapy

  2021cites this paper
• Identification of Novel Biomarkers in Hepatocellular Carcinoma by Integrated Bioinformatical Analysis and Experimental Validation

  2021cites this paper
• Synergistic effect of Chloroquine and Panobinostat in ovarian cancer through induction of DNA damage and inhibition of DNA repair

  2021cites this paper
• Broad-Spectrum HDAC Inhibitors Promote Autophagy through FOXO Transcription Factors in Neuroblastoma

  2021cites this paper
• Matairesinol, an active constituent of HC9 polyherbal formulation, exhibits HDAC8 inhibitory and anticancer activity.

  2021cites this paper
• Autophagy and senescence in cancer therapy.

  2021cites this paper
• Epigenetics of T‐cell Lymphoma

  2021cites this paper
• Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives

  2021cites this paper
• G9a/GLP methyltransferases inhibit autophagy by methylation-mediated ATG12 protein degradation

  2021cites this paper
• Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

  2021cites this paper
• Thiazolidinedione "Magic Bullets" Simultaneously Targeting PPARγ and HDACs: Design, Synthesis, and Investigations of their In Vitro and In Vivo Antitumor Effects.

  2021cites this paper
• Caspase3-deficient cells require fibronectin for protection against autophagy-dependent death

  2021cites this paper
• Changes in the Expression of TBP-2 in Response to Histone Deacetylase Inhibitor Treatment in Human Endometrial Cells

  2021cites this paper
• Miconazole induces autophagic death in glioblastoma cells via reactive oxygen species-mediated endoplasmic reticulum stress

  2021cites this paper
• Therapeutic evaluation of palbociclib and its compatibility with other chemotherapies for primary and recurrent nasopharyngeal carcinoma

  2020cites this paper
• Experimental studies of boron neutron capture therapy (BNCT) using histone deacetylase inhibitor (HDACI) sodium butyrate, as a complementary drug for the treatment of poorly differentiated thyroid cancer (PDTC).

  2020cites this paper
• Histone Deacetylase Inhibitors and Papillary Thyroid Cancer.

  2020cites this paper
• Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy

  2020cites this paper
• Romidepsin (FK228) regulates the expression of the immune checkpoint ligand PD-L1 and suppresses cellular immune functions in colon cancer

  2020cites this paper
• LncRNA NEAT1/miR-129/Bcl-2 signaling axis contributes to HDAC inhibitor tolerance in nasopharyngeal cancer

  2020cites this paper
• ZNF322A-mediated protein phosphorylation induces autophagosome formation through modulation of IRS1-AKT glucose uptake and HSP-elicited UPR in lung cancer

  2020cites this paper
• Therapeutic Evaluation of Palbociclib and Its Compatibility with Other Chemotherapies in Primary and Recurrent Nasopharyngeal Carcinoma

  2020cites this paper
• Recent progress on HDAC inhibitors with dual targeting capabilities for cancer treatment.

  2020cites this paper
• Polycythemia vera: the current status of preclinical models and therapeutic targets

  2020cites this paper
• Synergistic effects of BKM120 and panobinostat on pre-B acute lymphoblastic cells: an emerging perspective for the simultaneous inhibition of PI3K and HDACs

  2020cites this paper
• Epidermal Growth Factor Receptor and its trafficking regulation by acetylation: Implication in resistance and exploring the newer therapeutic avenues in cancer.

  2020cites this paper
• Inhibitory mechanism of muscone in liver cancer involves the induction of apoptosis and autophagy

  2020cites this paper
• In vitro and computational studies of natural products related to perezone as anti-neoplastic agents.

  2020cites this paper
• Molecular mechanisms underlying eicosapentaenoic acid inhibition of HDAC1 and DNMT expression and activity in carcinoma cells.

  2020cites this paper
• Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents: A review.

  2020cites this paper
• Targeted therapy for mTORC1-driven tumours through HDAC inhibition by exploiting innate vulnerability of mTORC1 hyper-activation

  2020cites this paper
• MIR145-3p promotes autophagy and enhances bortezomib sensitivity in multiple myeloma by targeting HDAC4

  2020cites this paper
• Ferroptosis is a type of autophagy-dependent cell death.

  2020cites this paper
• The Role of Autophagy in Pancreatic Cancer: From Bench to the Dark Bedside

  2020cites this paper
• Retracted: Innovative Therapies against Human Glioblastoma Multiforme

  2019cites this paper
• Induction of Apoptosis and Autophagy in Breast Cancer Cells by a Novel HDAC8 Inhibitor

  2019influential citation
• α,ß-Didehydrosuberoylanilide hydroxamic acid (DDSAHA) as precursor and possible analogue of the anticancer drug SAHA

  2019cites this paper